Unknown

Dataset Information

0

1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and in silico studies.


ABSTRACT: In the current work, some 1,3,4-oxadiazole-naphthalene hybrids were designed and synthesised as VEGFR-2 inhibitors. The synthesised compounds were evaluated in vitro for their antiproliferative activity against two human cancer cell lines namely, HepG-2 and MCF-7. Compounds that exhibited promising cytotoxicity (5, 8, 15, 16, 17, and 18) were further evaluated for their VEGFR-2 inhibitory activities. Compound 5 showed good antiproliferative activity against both cell lines and inhibitory effect on VEGFR-2. Besides, it induced apoptosis by 22.86% compared to 0.51% in the control (HepG2) cells. This apoptotic effect was supported by a 5.61-fold increase in the level of caspase-3 compared to the control cells. Moreover, it arrested the HepG2 cell growth mostly at the Pre-G1 phase. Several in silico studies were performed including docking, ADMET, and toxicity studies to predict binding mode against VEGFR-2 and to anticipate pharmacokinetic, drug-likeness, and toxicity of the synthesised compounds.

SUBMITTER: Hagras M 

PROVIDER: S-EPMC8725909 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications

1,3,4-Oxadiazole-naphthalene hybrids as potential VEGFR-2 inhibitors: design, synthesis, antiproliferative activity, apoptotic effect, and <i>in silico</i> studies.

Hagras Mohamed M   Saleh Marwa A MA   Ezz Eldin Rogy R RR   Abuelkhir Abdelrahman A AA   Khidr Emad Gamil EG   El-Husseiny Ahmed A AA   El-Mahdy Hesham A HA   Elkaeed Eslam B EB   Eissa Ibrahim H IH  

Journal of enzyme inhibition and medicinal chemistry 20221201 1


In the current work, some 1,3,4-oxadiazole-naphthalene hybrids were designed and synthesised as VEGFR-2 inhibitors. The synthesised compounds were evaluated <i>in vitro</i> for their antiproliferative activity against two human cancer cell lines namely, HepG-2 and MCF-7. Compounds that exhibited promising cytotoxicity (<b>5</b>, <b>8</b>, <b>15</b>, <b>16</b>, <b>17</b>, and <b>18</b>) were further evaluated for their VEGFR-2 inhibitory activities. Compound <b>5</b> showed good antiproliferative  ...[more]

Similar Datasets

| S-EPMC10854447 | biostudies-literature
| S-EPMC7241536 | biostudies-literature
| S-EPMC11393688 | biostudies-literature
| S-EPMC10609154 | biostudies-literature
| S-EPMC11783063 | biostudies-literature
| S-EPMC9947975 | biostudies-literature
| S-EPMC9879182 | biostudies-literature
| S-EPMC8591727 | biostudies-literature
| S-EPMC9327782 | biostudies-literature